STONY BROOK, N.Y.
(November 20, 2017) – Applied DNA Sciences, Inc.
(NASDAQ: APDN; “Applied DNA”) today announced that the Defense Logistics Agency (DLA) has awarded the Company a one-year extension of its current contract through October 13, 2018. This agreement maintains consistent support of the DNA marking lab originally established December 2014 at DLA’s Land and Maritime facility in Columbus, OH. With a focus on Federal Supply Class 5962 microcircuits, Applied DNA provides DLA’s Electronic Product Test Center (PTC) with full support including creation of SigNature® DNA marks, related equipment and supplies, services and continuous improvement.
“My team and I are proud to be part of Land and Maritime’s strategic initiative to identify and manage supply-system risks with the use of innovative DNA technology that can be inserted into DLA acquisition programs to meet specific defense needs. To date, over 800,000 microcircuits have been DNA marked,” stated Janice Meraglia, vice president of Government and Military Programs at Applied DNA. “It is an honor to continue to work with the PTC team in Columbus to keep our Warfighters safe.”
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
We make life real and safe by providing innovative, molecular-based technology solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. The proprietary DNA-based “CertainT®” platform can be used to identify, tag, test, and track products, to help assure authenticity, origin, traceability, sustainability and quality of products.
SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopyable, security and authentication solutions such as SigNature®T and fiberTyping®, targeted towards textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. Applied DNA Sciences is also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.
The statements made by APDN in this press release may be “forward-looking” in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K filed on December 6, 2016, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2017, May 11, 2017 and August 10, 2017 which are available at www.sec.gov
. APDN , undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.